Volume 2 - Issue 5, September - October 2026
π Paper Information
| π Paper Title | Detrminants of Financial Reporting Quality of Listed Pharmaceutical Companies in Nigeria |
| π€ Authors | Stella Anthony Ukpe, Dorathy Chridtopher Akpan, Uwem Etim Uwah, Akwaowo Ernest Inyang |
| π Published Issue | Volume 2 Issue 5 |
| π Year of Publication | 2026 |
| π Unique Identification Number | IJAMRED-V2I5P20 |
| π Search on Google | Click Here |
π Abstract
Despite the adoption of International Financial Reporting Standards (IFRS) in Nigeria, evidence suggests that
financial reporting practices in the country remain below expectation. The main objective of this study was to
ascertain the determinants of financial reporting quality of listed pharmaceutical companies in Nigeria. The
determinants of financial reporting quality used in this study were management quality, audit committee
financial expertise, ownership structure and internal control systems. The research design adopted in this study
was ex post facto, secondary data were used and the population of the study was 7 listed pharmaceutical
companies of which census sampling technique was employed to retain them as the sample size of the study.
The technique of data analysis employed was ordinary least square regression analysis and the statistical
package used was E views version 13. The findings of the study revealed that management quality (Coef. = -
0.251; p = 0.0021) has significant negative effect on income smoothing; audit committee financial expertise
(Coef. -0.321; p = 0.0000)) has significant negative effect on income smoothing; ownership structure (Coef. =
0.018; p = 0.0562) has nonsignificant negative effect on income smoothing and internal control system (Coef.
= -0.208; p = 0.001) has significant negative effect on income smoothing of listed pharmaceutical companies in
Nigeria. Thus, it was concluded that management quality, audit committee financial expertise and internal
control systems are major determinants of financial reporting quality of pharmaceutical firms in Nigeria. It was
therefore recommended amongst others that the board of directors should make educational qualifications and
professional competence key criteria in the selection and promotion of CEO. Also that The financial reporting
council of Nigeria (FRCN) and Security and Exchange Commission (SEC) should enforce compliance with
corporate governance codes that emphasize financial literacy of audit committee members
π How to Cite
Stella Anthony Ukpe, Dorathy Chridtopher Akpan, Uwem Etim Uwah, Akwaowo Ernest Inyang,"Detrminants of Financial Reporting Quality of Listed Pharmaceutical Companies in Nigeria" International Journal of Advanced Multidisciplinary Research and Educational Development, V2(5): Page(153-164) September - October 2026. ISSN: 3107-6513. www.ijamred.com. Published by Scientific and Academic Research Publishing.
